Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery Stenosis: Six-Month Clinical and Imaging Outcomes

J. A. Ormiston, B. de Bruyne, E. Regar, D. Dudek, L. Thuesen, P. C. Smits, B. Chevalier, D. McClean, J. Koolen, S. Windecker, R. Whitbourn, I. Meredith, C. Dorange, S. Veldhof, K. Miquel-Hebert, R. Rapoza, H. M. Garcia-Garcia, P. W. Serruys, Y. Onuma
  • Circulation, November 2010, Wolters Kluwer Health
  • DOI: 10.1161/circulationaha.110.970772
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
The following have contributed to this page: Dr E Regar